Regensdorf, Switzerland

Sylvia Herter

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 8.2

ph-index = 5

Forward Citations = 179(Granted Patents)


Location History:

  • Regensdorf, CH (2016 - 2021)
  • Schlieren, CH (2021 - 2022)

Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Sylvia Herter: Innovator in Antibody Research

Introduction

Sylvia Herter is a prominent inventor based in Regensdorf, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of modified antibodies and immunotherapeutic agents. With a total of seven patents to her name, her work has the potential to impact the treatment of various diseases.

Latest Patents

Her latest patents include "Antibody fab and Fc variants," which focuses on modified antibodies with altered abilities to induce direct cell death and effector function. This invention encompasses recombinant monoclonal antibodies, nucleic acid molecules encoding these antibodies, and methods for their production and application in disease treatment. Another notable patent is for "Mutant interleukin-2 polypeptides," which relates to polypeptides that exhibit reduced affinity to the α-subunit of the IL-2 receptor. This invention aims to utilize these mutant IL-2 polypeptides as immunotherapeutic agents, along with immunoconjugates and methods for their production and use.

Career Highlights

Throughout her career, Sylvia has worked with renowned companies such as Roche Glycart AG and Hoffmann-La Roche Inc. Her experience in these organizations has allowed her to refine her expertise in antibody research and development.

Collaborations

Some of her notable coworkers include Peter Bruenker and Christian Klein. Their collaboration has likely contributed to the advancement of her innovative projects and patents.

Conclusion

Sylvia Herter's work in the field of antibody research exemplifies the impact of innovation in biotechnology. Her patents and collaborations highlight her commitment to advancing medical treatments through scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…